blood cancer

02/26/2014 - 14:14

A diverse team of scientists from UCLA's Jonsson Comprehensive Cancer Center has developed an experimental treatment that eradicates an acute type of leukemia in mice without any detectable toxic side effects. The drug works by blocking two important metabolic pathways that the leukemia cells need to grow and spread.

 

12/17/2013 - 12:36

Researchers at the Moffitt Cancer Center have discovered a control mechanism that can trigger the development of myelodysplastic syndromes (MDS), a group of blood cancers.  This finding may lead to therapies capable of preventing the progression of these diseases.

 

08/18/2013 - 21:30

A gene that helps control the ageing process by acting as a cell’s internal clock has been linked to cancer by a major new study. Scientists at The Institute of Cancer Research, London, found a genetic variant that influences the ageing process among four new variants they linked to myeloma – one of the most common types of blood cancer.

 

05/01/2013 - 13:48

A team of researchers led by Washington University School of Medicine in St. Louis has identified virtually all of the major mutations that drive acute myeloid leukemia (AML), a fast-growing blood cancer in adults that often is difficult to treat.

 

03/18/2013 - 20:09

  A new population-based study from Karolinska Institutet has shown that the survival rate for patients with Hodgkin lymphoma - a form of cancer of the lymphatic system - has seen considerable improvements in recent decades. The number of patients suffering from treatment-related heart complications with fatal consequences has for example reduced as a result of new treatment strategies. Over 5,000 patients were involved in the study published in the scientific journal, Journal of Clinical Oncology.

02/15/2013 - 13:27

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens. They have also discovered that pairing Avastin with another cancer drug, dasatinib, can stop that lethal spread. Dasatinib is approved for use in several blood cancers.